Market Tracker

05/27 5:16pm ET

Alkermes Plc (NASDAQ:ALKS)

46.13
Delayed Data
As of May 27
 +1.84 / +4.15%
Today’s Change
27.14
Today|||52-Week Range
80.71
-41.89%
Year-to-Date

Today’s Trading

Previous close44.29
Today’s open44.28
Day’s range44.17 - 46.21
Volume1,285,595
Average volume (3 months)1,714,714
Market cap$7.0B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-623.81%
Earnings growth (this year)+18.76%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+1.54%
P/E ratioNM
Price/Sales18.85
Price/Book5.29

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+1.35+2.20%
TAROTaro Pharmaceutical ...+9.66+6.92%
RDYDr.Reddy's Laborator...+0.63+1.38%
IDXXIDEXX Laboratories I...+0.33+0.37%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$628.3M
Annual profit (last year)-$227.2M
Net profit margin-36.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts